Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade
Phase of Trial: Phase I
Latest Information Update: 23 Aug 2019
Price : $35 *
At a glance
- Drugs Nivolumab (Primary) ; Relatlimab (Primary) ; Contrast media
- Indications Glioblastoma
- Focus Adverse reactions; Pharmacodynamics
- 29 May 2019 Planned number of patients changed from 15 to 20.
- 20 Sep 2018 Planned initiation date (estimated date for recruitment of the first subject) changed from 20 Sep 2018 to 26 Sep 2018.
- 14 Sep 2018 Planned initiation date (estimated date for recruitment of the first subject) changed from 12 Sep 2018 to 20 Sep 2018.